|
|
|
Volumn 44, Issue 2, 2012, Pages 140-144
|
|
Effect of oral N-acetylcysteine treatment on immune system in continuous ambulatory peritoneal dialysis patients.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACETYLCYSTEINE;
ANTIOXIDANT;
BIOLOGICAL MARKER;
C REACTIVE PROTEIN;
CALCITONIN;
COMPLEMENT COMPONENT C3;
INTERLEUKIN 1;
INTERLEUKIN 6;
PROCALCITONIN;
PROTEIN PRECURSOR;
TUMOR NECROSIS FACTOR ALPHA;
ADULT;
ARTICLE;
BLOOD;
CHRONIC KIDNEY FAILURE;
CLINICAL TRIAL;
CONTINUOUS AMBULATORY PERITONEAL DIALYSIS;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG EFFECT;
FEMALE;
HUMAN;
IMMUNOLOGY;
INFLAMMATION;
MALE;
METABOLISM;
MIDDLE AGED;
OXIDATIVE STRESS;
RANDOMIZED CONTROLLED TRIAL;
ACETYLCYSTEINE;
ADULT;
ANTIOXIDANTS;
BIOLOGICAL MARKERS;
C-REACTIVE PROTEIN;
CALCITONIN;
COMPLEMENT C3;
FEMALE;
HUMANS;
INFLAMMATION;
INTERLEUKIN-1;
INTERLEUKIN-6;
KIDNEY FAILURE, CHRONIC;
MALE;
MIDDLE AGED;
OXIDATIVE STRESS;
PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY;
PROTEIN PRECURSORS;
TUMOR NECROSIS FACTOR-ALPHA;
|
|
EID: 84871866400
PISSN: 01259326
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (25)
|
|
References (0)
|
